New Brunswick Scientific Completes Merger Transaction with Eppendorf
24 Septembre 2007 - 8:39PM
PR Newswire (US)
EDISON, N.J., Sept. 24 /PRNewswire-FirstCall/ -- New Brunswick
Scientific Co., Inc. ("NBS") (NASDAQ:NBSC), and Eppendorf Group
("Eppendorf") announced today the completion of the previously
announced merger transaction in which Eppendorf acquired NBS for
approximately $110 million in an all-cash transaction. As a result
of the merger, which was approved by NBS' shareholders at a special
meeting on September 20, 2007, NBS' shareholders are entitled to
receive $11.50 per share in cash. NBS has notified the NASDAQ
Global Market of the closing of the transaction and expects that no
further trading in NBS stock will occur after today and that its
shares will no longer be listed. Eppendorf has appointed American
Stock Transfer & Trust Company as paying agent, and, will
promptly mail a letter of transmittal and instructions to all NBS
shareholders of record. The letter of transmittal and instructions
will contain information on how to surrender stock certificates
representing shares of NBS common stock in exchange for $11.50 per
share, without interest. NBS' shareholders of record should wait
until they receive the letter of transmittal before surrendering
their stock certificates. Shareholders who hold shares through a
bank or broker will not have to take any action to have their
shares exchanged for the merger consideration as such exchanges
will be handled by the bank or broker. About New Brunswick
Scientific New Brunswick Scientific Co., Inc., is a leading global
innovator providing a comprehensive line of equipment and
instrumentation for the life science industry. NBS's products are
used in the creation, maintenance and control of physical and
biochemical environments required for the growth, detection and
storage of microorganisms for medical, biological and chemical
applications, environmental research and commercial products.
Established in 1946, NBS is headquartered in Edison, New Jersey,
with sales and distribution facilities located in the United
States, Europe and Asia. News releases and other information on NBS
are available on the Internet at: http://www.nbsc.com/. About
Eppendorf Eppendorf is a global leader in laboratory equipment and
associated consumables. Eppendorf products include liquid handling
and centrifugation equipment products including related consumables
as well as instruments and systems for PCR, cell technology and
micro arrays that are used by researchers in life science, drug
discovery, clinical, environmental and industrial laboratories.
Founded in 1945, Eppendorf, a privately-held company headquartered
in Hamburg, Germany, has revenues of more than $400 million, and
employs approximately 2,000 people in over 20 countries. News
releases and other information on Eppendorf are available on the
Internet at: http://www.eppendorf.com/. DATASOURCE: New Brunswick
Scientific Co., Inc. CONTACT: Investors, Thomas Bocchino, Vice
President, Finance and Treasurer, of New Brunswick Scientific Co.,
Inc., +1-732-650-2500, ; or Matthew J. Dennis, CFA, NBS Investor
Relations, of Clear Perspective Group, LLC, +1-732-226-3030, Web
site: http://www.nbsc.com/ http://www.eppendorf.com/
Copyright
New Brunswick Scientific (NASDAQ:NBSC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
New Brunswick Scientific (NASDAQ:NBSC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about New Brunswick Scient (MM) (NASDAQ): 0 recent articles
Plus d'articles sur New Brunswick Scientific CO. (MM)